Gene · 2114
Papers2,490
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,490
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of H2O2-Induced Alterations in Global Transcription of mRNA and lncRNA. | Antioxidants (Basel) | 2022 | 35326145 | PubTator, text mining | PubMed |
| Exosome-derived noncoding RNAs: Function, mechanism, and application in tumor angiogenesis. | Mol Ther Nucleic Acids | 2022 | 35317280 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| Type I interferon transcriptional network regulates expression of coinhibitory receptors in human T cells. | Nat Immunol | 2022 | 35301508 | PubTator, text mining | PubMed |
| MiR-7-5p suppresses invasion via downregulation of the autophagy-related gene ATG7 and increases chemoresistance to cisplatin in BCa. | Bioengineered | 2022 | 35300572 | PubTator, text mining | PubMed |
| Functional characterization of the human Cdk10/Cyclin Q complex. | Open Biol | 2022 | 35291876 | PubTator, text mining | PubMed |
| MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma. | Sci Rep | 2022 | 35264666 | PubTator, text mining | PubMed |
| [Molecular pathogenesis and therapeutic targets in acute erythroid leukemia]. | Rinsho Ketsueki | 2022 | 35264503 | PubTator, text mining | PubMed |
| Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors. | Mol Cancer Ther | 2022 | 35247919 | PubTator, text mining | PubMed |
| Characterisation of the Circulating Transcriptomic Landscape in Inflammatory Bowel Disease Provides Evidence for Dysregulation of Multiple Transcription Factors Including NFE2, SPI1, CEBPB, and IRF2. | J Crohns Colitis | 2022 | 35212366 | PubTator, text mining | PubMed |
| Screening for Regulatory Network of miRNA-Inflammation, Oxidative Stress and Prognosis-Related mRNA in Acute Myocardial Infarction: An in silico and Validation Study. | Int J Gen Med | 2022 | 35210840 | PubTator, text mining | PubMed |
| Whole Genome Sequencing Unravels New Genetic Determinants of Early-Onset Familial Osteoporosis and Low BMD in Malta. | Genes (Basel) | 2022 | 35205249 | PubTator, text mining | PubMed |
| Regulation of p53 Function by Formation of Non-Nuclear Heterologous Protein Complexes. | Biomolecules | 2022 | 35204825 | PubTator, text mining | PubMed |
| Comprehensive Statistical and Bioinformatics Analysis in the Deciphering of Putative Mechanisms by Which Lipid-Associated GWAS Loci Contribute to Coronary Artery Disease. | Biomedicines | 2022 | 35203469 | PubTator, text mining | PubMed |
| The Evolution of Biomineralization through the Co-Option of Organic Scaffold Forming Networks. | Cells | 2022 | 35203246 | PubTator, text mining | PubMed |
| The therapeutic potential of RNA Polymerase I transcription inhibitor, CX-5461, in uterine leiomyosarcoma. | Invest New Drugs | 2022 | 35201535 | PubTator, text mining | PubMed |
| A curious case of cyclin-dependent kinases in neutrophils. | J Leukoc Biol | 2022 | 35188696 | PubTator, text mining | PubMed |
| Overexpression of CAPG Is Associated with Poor Prognosis and Immunosuppressive Cell Infiltration in Ovarian Cancer. | Dis Markers | 2022 | 35186171 | PubTator, text mining | PubMed |
| Comment on 'Long noncoding RNA UCA1 promotes glutamine-driven anaplerosis of bladder cancer by interacting with hnRNP I/L to upregulate GPT2 expression' by Chen et al.'". | Transl Oncol | 2022 | 35182956 | PubTator, text mining | PubMed |
| The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles. | Transl Oncol | 2022 | 35168143 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2114/papers?page=23